Results 1 to 10 of about 328 (75)

Private Label: o potencial impacto no mercado de medicamentos no Brasil

Revista De Economia Mackenzie
The objective of this article is to discuss how the release of private labels would change the dynamics of the industry with the eventual concentration of the retailer’s power in the medicines market. To this end, important theoretical aspects will be raised, based, for example, on Michael Porter’s theory (Five Competitive Forces and Value Chain). As a
Ronaldo Raemy Rangel, Luan Vinicius Bernardelli, Paulo Rogério Alves Brene   +2 more
exaly   +3 more sources

Swap It on WhatsApp: The Moral Economy of Informal Online Exchange Networks in Contemporary Cuba

The Journal of Latin American and Caribbean Anthropology, Volume 27, Issue 1-2, Page 80-100, June 2022., 2022
Abstract The inhabitants of Cuba's capital, Havana, are using semipublic group chats on messaging applications such as WhatsApp and Telegram to access food, hygiene products, medication, and other basic necessities during times of scarcity. This has been especially prevalent during the COVID‐19 pandemic. Such chat groups created digital spaces in which
Steffen Köhn, Nestor Siré
wiley   +1 more source

A vision for integrated publicly available information on regulated medical products

, 2022
Clinical and Translational Science, Volume 15, Issue 6, Page 1321-1327, June 2022.
Khyati Roberts, Roopal Thakkar, Lina Aljuburi, Donna Boyce, Sean Curtis, Jennifer Dudinak, Helen Fitton, Carlos Garner, Michael Garvin, Susan Longman, Edward Reilly, Jordan Maitland, Alexis Reisin Miller, Muriel Pasté, Michelle Rohrer, Mark Taisey, Karin Van Baelen, Max Wegner   +17 more
wiley   +1 more source

Policy Effectiveness in Managing Drug Shortages: Evidence From South Korea (2015–2024)

World Medical &Health Policy, Volume 17, Issue 3, Page 561-572, September 2025.
ABSTRACT Drug shortages represent a growing policy challenge for healthcare systems worldwide. This study investigates actual drug shortage events in South Korea from 2015 to 2024, using a “Shortage Occurred vs. Shortage Non‐Occurred” framework to distinguish real‐world disruptions from administrative classifications.
Seung‐Rae Yu
wiley   +1 more source

Cost‐Effectiveness of Preemptive Plerixafor Versus Rescue Plerixafor for Mobilization and Collection of Hematopoietic Stem Cells in Patients With Multiple Myeloma and Lymphoma

Journal of Clinical Apheresis, Volume 40, Issue 3, June 2025.
ABSTRACT Background Plerixafor combined with granulocyte colony‐stimulating factor (G‐CSF) has shown superior efficacy in mobilizing hematopoietic stem cells (HSCs). However, its widespread use is constrained by high costs, and there is ongoing debate regarding the effectiveness of mobilization strategies. This study evaluated the cost‐effectiveness of
Roselene Mesquita Augusto Passos, Miriam Allein Zago Marcolino, Júlia Augusto Passos, Vinicius Fernando Calsavara, Leila de Lourdes Martins Perobelli, Alessandro Gonçalves Campolina, Cesar de Almeida‐Neto   +6 more
wiley   +1 more source

[Impact of an integrated and centralized drug policy: the case of the province of Buenos Aires, ArgentinaImpacto de uma política de medicamentos integrada e centralizada: o caso da província de Buenos Aires, Argentina]. [PDF]

Rev Panam Salud Publica
Marín GH, Capallo AP, Cocco MH, Álvarez JI, Leone F, Pesci SA, Konfino J, Kreplak N.   +7 more
europepmc   +1 more source

Prices paid for primary health care medicines by Brazilian municipalities. [PDF]

Rev Saude Publica
Silva WROD, Cavalcanti ITDN, Peters JR, Ferreira LEMDS, Santana RS, Leite SN.   +5 more
europepmc   +1 more source

Prevalence and factors associated with self-medication among schoolchildren in the Metropolitan Region of Vitória, Brazil. [PDF]

Rev Esc Enferm USP
Mairink KR, Miguez FGG, Lopes CA, Camboin FF, Santana NMT, Pereira NBR, Leite FMC.   +6 more
europepmc   +1 more source

[The survival of Antiquity on the covers and int he drug ads of Eu Sei Tudo magazine, 1917-1958]. [PDF]

Hist Cienc Saude Manguinhos
Maia ACN, Liborio DS.
europepmc   +1 more source

Consumption of drugs for Alzheimer's disease on the Brazilian private market. [PDF]

Rev Saude Publica, 2023
Freitas EL, Calil-Elias S, Erbisti RS, Grinberg-Weller B, Miranda ES.   +4 more
europepmc   +1 more source